Annual report pursuant to Section 13 and 15(d)

Estimated Fair Values of Assets Acquired and Liabilities Assumed (Detail)

v2.4.0.8
Estimated Fair Values of Assets Acquired and Liabilities Assumed (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended 0 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2012
Jul. 22, 2013
Bionostics Holdings, Ltd
Apr. 30, 2014
PrimeGene
Business Acquisition [Line Items]          
Current assets       $ 9,605 $ 1,272
Intangible Assets       60,500 14,622
Goodwill 151,473 84,336 85,682 56,349 5,518
Equipment       2,180 546
Total assets acquired       128,634 21,958
Liabilities       3,007 887
Deferred income taxes       22,478 2,310
Net assets acquired       103,149 18,761
Cash paid, net of cash acquired 109,180 0 0 103,149 6,031
Note payable       0 12,730
Net purchase price       $ 103,149 $ 18,761